Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires

SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced it has appointed Richard Baxter to the role of Senior Vice President of Investment Operations, and Karen Reeves, M.D., to Senior Vice President of Clinical Strategy and Investments. Both executives will report to CEO Todd Davis. “Rich and Karen strengthen our…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks